KANALYST is specialized in the study of ion channels and transporters. Our goal is to provide advanced scientific knowledge and intellectual input to support and accelerate your R&D projects in all aspects of ion channel engineering, biochemistry, electrophysiology, and pharmacology. In addition, we offer an array of in vitro assays from target validation to pharmacological screening. The company was initiated by Dr. Norbert Weiss.
Dr. Norbert Weiss completed his PhD at the University Joseph Fourier in France where he investigated how opioids mediate their analgesic effects via the modulation of ion channels. Norbert then completed a postdoctoral training in France at the university Claude Bernard and a second in Canada at the University of Calgary where he worked on the connection between ion channels and human disorders. Norbert is currently head of the laboratory Ion Channels and Diseases at the Institute of Organic Chemistry and Biochemistry in Prague where he specialized on the mechanisms underlying human pathologies caused by dysfunction of ion channels so-called channelopathies and the identification of new therapeutic targets.
We are proud of our customers! We are pleased with our close cooperation and that the solutions we have provided help to move their projects forward.